Northwest & Ethical Investments L.P. Regeneron Pharmaceuticals, Inc. Transaction History
Northwest & Ethical Investments L.P.
- $4.24 Trillion
- Q3 2025
A detailed history of Northwest & Ethical Investments L.P. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Northwest & Ethical Investments L.P. holds 460 shares of REGN stock, worth $319,010. This represents 0.01% of its overall portfolio holdings.
Number of Shares
460Holding current value
$319,010% of portfolio
0.01%Shares
10 transactions
Others Institutions Holding REGN
# of Institutions
1,467Shares Held
86.5MCall Options Held
2.42MPut Options Held
1.64M-
Vanguard Group Inc Valley Forge, PA9.05MShares$6.27 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.69MShares$3.25 Billion0.09% of portfolio
-
Dodge & Cox San Francisco, CA4.55MShares$3.16 Billion1.47% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.82 Billion0.15% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...